| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
472 |
390 |
$70K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
551 |
476 |
$58K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
280 |
232 |
$55K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,518 |
1,334 |
$27K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
212 |
202 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
340 |
311 |
$17K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
135 |
128 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
374 |
333 |
$15K |
| 80061 |
Lipid panel |
359 |
344 |
$14K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
74 |
70 |
$14K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
354 |
347 |
$11K |
| 80053 |
Comprehensive metabolic panel |
354 |
321 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
842 |
608 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
139 |
130 |
$7K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
102 |
89 |
$6K |
| 84100 |
|
252 |
239 |
$5K |
| 82248 |
|
256 |
243 |
$5K |
| 82565 |
|
237 |
220 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
53 |
50 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
17 |
16 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
98 |
91 |
$3K |
| 87081 |
|
104 |
98 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
15 |
15 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
20 |
13 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
79 |
69 |
$2K |
| 0011A |
|
38 |
38 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$998.99 |
| 0012A |
|
35 |
35 |
$961.77 |
| 82947 |
|
84 |
81 |
$897.72 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
36 |
29 |
$733.87 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$606.39 |
| 83718 |
|
12 |
12 |
$598.23 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
16 |
13 |
$568.89 |
| 83655 |
|
15 |
15 |
$554.26 |
| 11721 |
|
21 |
12 |
$484.16 |
| 82465 |
|
12 |
12 |
$368.40 |
| 85018 |
|
16 |
16 |
$350.40 |
| 83605 |
|
14 |
13 |
$299.69 |
| 85027 |
|
13 |
13 |
$248.30 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
18 |
12 |
$202.92 |
| 84460 |
|
13 |
13 |
$198.36 |
| 84132 |
|
13 |
13 |
$134.85 |
| 81001 |
|
16 |
13 |
$131.12 |
| 86140 |
|
13 |
13 |
$126.70 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
421 |
295 |
$105.93 |
| 85610 |
|
13 |
12 |
$53.76 |
| 91301 |
|
68 |
68 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
20 |
15 |
$0.00 |